Mesalamine Capsule, Extended Release
Product Images NDC 68382-452

2 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 68382-452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Eec692f7 504b 4f61 A5c6 E925db3a58b2 01)

Image (Eec692f7 504b 4f61 A5c6 E925db3a58b2 01)
Chemical structure of mesalamine, showing its molecular components including an amino group, hydroxyl groups, and a carboxyl group attached to a benzene ring.*
FDA Label Image

Image (Eec692f7 504b 4f61 A5c6 E925db3a58b2 02)

Image (Eec692f7 504b 4f61 A5c6 E925db3a58b2 02)
Mesalamine Extended-Release Capsules, USP 0.375 g oral dosage form label. The packaging shows 120 capsules per container, labeled for prescription use only. Manufactured by Zydus Lifesciences Ltd., Ahmedabad, India, and distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ. The label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.